1. Casey, Stephanie C, Tong, Ling, Li, Yulin, Eilers, Martin, Felsher, Dean W. 2016. MYC regulates the antitumor immune response through CD47 and PD-L1. In Science (New York, N.Y.), 352, 227-31. doi:10.1126/science.aac9935. https://pubmed.ncbi.nlm.nih.gov/26966191/
2. Hu, Li-Yang, Zhuang, Wei-Tao, Chen, Mao-Jian, Zhang, Li, Fang, Wen-Feng. 2024. EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47. In Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 19, 1186-1200. doi:10.1016/j.jtho.2024.03.019. https://pubmed.ncbi.nlm.nih.gov/38553005/
3. Zhang, Peng, Rashidi, Aida, Zhao, Junfei, Miska, Jason, Lesniak, Maciej S. 2023. STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. In Nature communications, 14, 1610. doi:10.1038/s41467-023-37328-9. https://pubmed.ncbi.nlm.nih.gov/36959214/
4. Yu, Lan, Ding, Yi, Wan, Ting, Huang, He, Liu, Jihong. 2021. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer. In Frontiers in immunology, 12, 768115. doi:10.3389/fimmu.2021.768115. https://pubmed.ncbi.nlm.nih.gov/34966389/
5. Hsieh, Rodney Cheng-En, Krishnan, Sunil, Wu, Ren-Chin, Rudqvist, Nils-Petter, Curran, Michael A. 2022. ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer. In Science immunology, 7, eabl9330. doi:10.1126/sciimmunol.abl9330. https://pubmed.ncbi.nlm.nih.gov/35687697/
6. Hu, Tuo, Liu, Huashan, Liang, Zhenxing, Wu, Xianrui, Lan, Ping. 2020. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis. In Theranostics, 10, 4056-4072. doi:10.7150/thno.40860. https://pubmed.ncbi.nlm.nih.gov/32226539/
7. Shi, Yaoyao, Zheng, Wenxin, Yang, Kaiting, Weichselbaum, Ralph R, Fu, Yang-Xin. . Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. In The Journal of experimental medicine, 217, . doi:10.1084/jem.20192282. https://pubmed.ncbi.nlm.nih.gov/32142585/
智鼠故事 
